News · page 7

From the very start of the health crisis, the REACTing consortium team has been at the front line, coordinating studies on COVID-19. That is why it has been selected to receive the OPECST-Inserm Prize for social impact through its director, Yazdan Yazdanpanah, specialist of infectious diseases and director of the Inserm Immunology, Inflammation, Infectious Diseases and […]

In addition to being an Inserm* researcher, Florence Ader is a clinician treating patients in the field. It is in honor of this dual role that has she has been selected to lead the large-scale clinical trial Discovery … and to receive the Research Prize! Among the COVID-19 experts, Florence Ader is one of the […]

A key medical research discipline, biostatistics ensures the rigor of studies conducted in patients. Not surprising then that biostatistician France Mentré and her colleagues have been extensively involved in COVID-19 clinical research at Inserm. It is in honor of their work that Inserm has awarded them its Research Prize. At the crossroads of mathematics, computer […]

Leading AIDS specialist and deputy director of the Pierre Louis Institute of Epidemiology and Public Health (iPLESP)*, Dominique Costagliola has been at the front line of the war on COVID since January 2020. With one objective: use her expertise to further research. It is in honor of her work and that of her team that […]

An internationally renowned expert in infectious diseases, Anthony Fauci plays a key role in informing the general public on COVID-19, and in terms of strategies and advice on how to best contain the pandemic. It is in recognition of this role that Inserm has awarded him its International Prize. Anthony Fauci was already a « celebrity » […]

During the current health crisis, Inserm Legal Affairs Department director Jean-Christophe Hébert and his team have also been highly active in setting up the contracts necessary for the Institute’s COVID-19 research projects. It is in honor of his efficacy that he has been awarded the Innovation Prize. « An Inserm product, through and through » is how […]

During the current health crisis, Inserm Clinical Research Unit manager Hélène Espérou and her team have supported the preparation of the Institute’s research projects as part of their mission to supervise clinical trials. It is in honor of her commitment that she has been awarded the Innovation Prize. Hélène Espérou joined Inserm in 2017 after […]

Respiratory syncytial virus (RSV) is one of the deadliest respiratory viruses, especially in young children. However, deciphering the mechanisms that allow its entry into the host cell has not led to any effective treatments so far. What if the solution lay downstream of these early stages of the viral cycle? This is the avenue that […]

When the COVID-19 epidemic began to gather momentum in France back in March 2020, the scientists from the Interferon and Antiviral Restriction team at the Infectious Disease Research Institute of Montpellier did not hesitate for long before tackling the study of its causative virus, SARS-CoV‑2. Six months later, how are they getting on? Join us for […]

Respiratory infections are the third leading cause of mortality worldwide, not helped by the emergence of antibiotic resistance in bacterial pneumonia. Jean-Claude Sirard is working on an innovative therapeutic avenue: the administration of a protein component of bacteria to reinforce natural immunity and the efficacy of antibiotic therapy in response to the infection. The researcher […]